Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction
HFpEF: From Mechanisms to Therapies
Left Ventricular Assist Devices for Lifelong Support
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

|<< 1 2 3 4 5 6 7 ...>>|

Review Article

2018;138:2841–2851

JOURNAL：Circulation.

Article Link

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

JJ Han, MA Acker, P Atluri et al.

330

Keywords: left ventricular assist device; heart failure; suck-down event; park stitch; HMIII artificial pulsatility; hemocompatability; quality-adjusted life years; incremental cost-effectiveness ratio

FULL TEXT PDF